Skip To Main Content
Chuanying Xu on Muck Rack

Chuanying Xu

As seen in: Nature, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chuanying

Contact Chuanying, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Alterations in gut microbiota and plasma metabolites: a multi-omics study of mild cognitive impairment in Parkinson’s disease

|
By Zihao Lin, Yangdanyu Li, Yuning Liu, Peixiao Yin, Chenyang Guan, Yating Fang, Liying Yang, Kun Zan, Lu Yu, Xiaojie Wang, Chuanying Xu, Guiyun Cui
| Frontiers
1Department of Neurology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China 2Department of Neurology, The First Clinical College, Xuzhou Medical University, Xuzhou, Jiangsu, China 3Department of Pharmacy, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China Introduction: Emerging evidence suggests that gut microbiota and plasma metabolites may be associated with the onset and progression of Parkinson’s disease (PD).
Open in Who Shared Issue with article?

A novel anti-HER2 antibody GB235 reverses Trastuzumab resistance in HER2-expressing tumor cells in vitro and in vivo

|
By Yan Wu, Mengjun Shu, Hongbin Yan, Chuanying Xu
| Nature Verified
Abstract HER2 overexpression is frequently associated with tumor metastasis and poor prognosis of breast cancer. More evidence indicates that HER3 is involved in HER2-resistant therapies. Combination treatments with two or more different monoclonal antibodies are a promising strategy to overcome resistance to HER2 therapies. We presented a novel fully human HER2-targeted monoclonal antibody, GB235, screened from a phage-display library against the HER2 antigen.
Open in Who Shared Issue with article?
See all 2 articles